What an MDT Discussion Is Meant to Decide
A multidisciplinary team discussion brings together clinicians from relevant specialties to review a complex or cross-specialty cancer case. For kidney cancer, that may involve urology, medical oncology, radiology and pathology. The purpose is not to repeat a single specialist's opinion but to reconcile different perspectives into a documented plan.
The specific questions an MDT should answer depend on whether the case is newly diagnosed, recurrent, or being reassessed after previous kidney procedures. A newly diagnosed case needs clarity on tumour extent, kidney function, and whether surgery is the appropriate first step. A recurrent or complex case needs discussion of how previous treatment affects current options.
The MDT should also answer what remains uncertain. If imaging cannot distinguish between partial and radical surgery, the discussion should state what additional information would resolve that question. If kidney function is borderline, the discussion should address how the proposed approach affects long-term renal capacity.
A useful MDT output is a written summary that names the recommended approach, the rationale, the alternatives considered, and the specific follow-up or preparation steps. Ask whether the hospital provides this summary in English or with translation.
Tumour and Kidney-Function Records the Discussion Needs
The quality of an MDT discussion depends on the records available. For kidney cancer, the core records include cross-sectional imaging of the abdomen, a pathology report if a biopsy or previous surgery has been performed, and recent kidney-function blood tests. These records allow the team to assess the lesion and the kidney together.
Partial nephrectomy removes part of a kidney. The proposed approach depends on the lesion and kidney assessment. That means the MDT needs to see not only the tumour's size and location but also how much healthy kidney tissue would remain after surgery. A discussion without both pieces of information cannot properly compare partial and radical approaches.
If previous kidney procedures have been performed, the operative notes and follow-up imaging are relevant. They show what was removed, what remains, and how the kidney has functioned since. Ask the hospital whether it needs the original imaging files or whether a radiology report is sufficient for the MDT review.
For an overseas enquiry, a brief summary of the diagnosis, the main question, and the available records is enough to start. The hospital or coordination team can then specify which additional documents are needed for the MDT discussion. Do not send a complete medical archive before you know what the review requires.
Partial Versus Radical Surgery: What the MDT Must Clarify
The choice between partial nephrectomy and radical nephrectomy is a central question for many kidney cancer cases. Partial nephrectomy removes part of a kidney. Radical nephrectomy removes the whole kidney. The MDT should explain why one approach is preferred over the other for this specific lesion and kidney.
The discussion should address whether partial removal is technically feasible given the tumour's location, size and relationship to major blood vessels and the collecting system. It should also address whether partial removal would leave enough healthy kidney tissue to maintain adequate function. If the answer is uncertain, the MDT should state what additional imaging or assessment would help.
The MDT should also consider the patient's overall health and any pre-existing kidney impairment. A patient with reduced kidney function may benefit from preserving as much kidney tissue as possible, but that must be weighed against the risk of incomplete tumour removal. The discussion should document how that balance was assessed.
Ask the MDT to explain what would happen if the planned approach needs to change during surgery. For example, if partial removal is attempted but the tumour cannot be safely separated from critical structures, what is the contingency? The answer should be part of the documented plan, not left to the operating room alone.
Questions to Ask About the MDT Format in China
Hospitals in China differ in how they organise multidisciplinary discussions. Some have a formal MDT meeting for complex cancer cases; others coordinate opinions through sequential consultations. The hospital decides whether an MDT format is available for your case, and that decision may depend on the case's complexity and the specialties involved.
When enquiring about kidney cancer care in China, ask directly: Which specialties will review my case? Will they meet together or provide separate opinions? Who coordinates the discussion, and how will the conclusion be communicated to me? These questions clarify the actual process rather than assuming a particular format.
Ask whether the MDT discussion is part of the standard pathway for kidney cancer or whether it requires a specific request. Ask what records the hospital needs before the discussion can take place, and whether those records must be in Chinese or can be reviewed in English. If translation is needed, ask who provides it.
The MDT discussion is a clinical review, not a guarantee of hospital acceptance or a specific treatment outcome. The hospital's treating team makes the final decision about suitability, and that decision may require an in-person assessment. An MDT review can inform the plan, but it does not replace the treating clinician's judgment.
How to Prepare Your Enquiry and Records
A useful enquiry starts with a short summary: the diagnosis or suspected diagnosis, the main question you need answered, and the records you already have. For kidney cancer, that typically includes imaging reports, pathology reports if available, and recent kidney-function blood tests. You do not need to send everything at once.
After the initial contact, the hospital or coordination team can tell you which specific documents are needed for the MDT discussion. They may ask for the original imaging files, a translated pathology report, or additional blood tests. Ask about the preferred format and whether secure transfer is available.
If you have had previous kidney surgery, include the operative notes and follow-up imaging in your summary. These help the MDT understand what has already been done and how it affects current options. If you do not have these records, ask the hospital whether they can proceed without them or whether obtaining them is necessary.
Keep a written list of your questions for the MDT. For example: Is partial nephrectomy feasible? What is the plan if it is not? How will kidney function be monitored? What are the alternatives if surgery is not recommended? A written list helps ensure the discussion addresses your priorities.
What the MDT Cannot Guarantee and What to Confirm Next
An MDT discussion cannot guarantee a specific outcome, confirm that partial nephrectomy is always feasible, or promise that the hospital will accept your case. It also cannot replace an in-person clinical assessment when the treating team needs to examine you or perform additional tests. The discussion is one step in planning, not a final clearance.
The MDT also cannot resolve every uncertainty. If the imaging does not clearly show the tumour's relationship to critical structures, the discussion may recommend further imaging or a different assessment. Ask what remains uncertain after the MDT and what steps would resolve those uncertainties.
For overseas patients, the practical next step is to send a brief summary of the diagnosis and your main question through the enquiry form, email or WhatsApp. An initial enquiry is free and does not require buying a proxy consultation. The team can then explain what records are needed and whether an MDT discussion is a suitable route for your case.
If you are already in China or planning to travel, ask the hospital about its process for coordinating the MDT discussion and how the conclusion will be shared with you. The hospital's treating team decides suitability, and any treatment plan remains subject to their clinical judgment.
Sources & scope of this guide
References and official service information relevant to this guide.
This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.